(Q38467225)
Statements
A phase 1, randomized, open-label, active-controlled trial to assess the safety of a meningococcal serogroup B bivalent rLP2086 vaccine in healthy adults (English)
Howard Schwartz
Qin Jiang
Peter C Giardina
scientific article published on July 2012